CND Life Sciences Email Format

Medical and Diagnostic LaboratoriesArizona, United States51-200 Employees

CND Life Sciences operates a CLIA-certified and CAP-accredited laboratory in Scottsdale, Arizona, focusing on diagnosing neurodegenerative conditions. It introduced the Syn-One Test, a lab-developed assay that identifies abnormal phosphorylated alpha-synuclein in skin nerves to support the diagnosis of synucleinopathies. The test uses three small skin biopsies provided by a referring physician, offering a minimally invasive way to aid in confirming conditions such as Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, or pure autonomic failure.

Within the medical and diagnostic laboratory sector, the company serves clinicians and patients seeking more objective assessment of synuclein-related neurodegenerative diseases. Based in Scottsdale, it operates as a mid-sized laboratory and collaborates with multiple biopharmaceutical companies to advance research in this field. In 2025, the company participated in AAIC 2025 to present updates from three clinical trials involving the skin biopsy diagnostic tool.

Sign up for free to view info

Company overview Employee directory